Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR

Journal of Korean Medical Science

Volumn 14, Issue 6, 1999, Pages 629-634

  Kim, Young Sik ^a   Lee, Hyo Suk ^b   Ahn, Yoon Ok ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Enzyme linked immunosorbent assay; Hepatitis C antibodies; Hepatitis C like virus; Reverse transcriptase polymerase chain reaction; Risk factors

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0033252293     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.6.629     Document Type: Article

References (22)

1. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, Van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317-9.
2. Kim DW, Han TJ, Chi HS, Kim YS. Seroprevalence of anti-HCV according to EIA in Korean blood donors; comparison of EIA results with confirmatory tests. Korean J Blood Transfusion 1993; 4: 223-9.
3. Chayama K, Tsubota A, Arase Y, Saitoh S, Koida I, Ikeda K, Matsumoto T, Kobayashi M, Iwasaki S, Koyama S, Morinaga T, Kumada H. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 1993; 8: 150-6.
4. Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon R. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation antihepatitis C virus screening test. Hepatology 1995; 21: 725-9.
5. Kim YS, Chi HS, Ahn YO, Lee HS, Klag MJ. Lack of familial clustering of hepatitis C virus infection. Int J Epidemiol 1998; 27: 525-9.
6. Alexis J, Lubin J, Bichachi A. Acupuncture and non-A, non-B hepatitis. Southern Med J 1988; 81: 101.
7. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993; 12: 673-6.
8. Kaldor JM, Archer GT, Buring ML, Ismay SL, Kenrick KG, Lien ASM, Purusothanman K, Tulloch R, Bolton WV, Wylie BR. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 1992; 157: 227-30.
9. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors - the role of parenteral and sexual transmission. Scand J Infect Dis 1995; 27: 99-104.
10. Mattsson L, Aberg B, von Sydow M, Weiland O. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden. Scand J Infect Dis 1991; 23: 25-9.
11. Mele A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA, Ferrigno L, Rapicetta M, Franco E, Adamo B, Palumbo F, Sbreglia C, Pana A, Pasquini P. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study. Am J Public Health 1994; 84: 1640-3.
12. Serfaty L, Giral P, Elghouzzi MH, Jullien AM, Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology 1993; 17: 183-7.
13. Piazza M, Borgia G, Picciotto L, Nappa S, Cicciarello S, Orlando R. Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. J Med Virol 1995; 45: 40-2.
14. Fabrizi F, Lunghi G, Pagliari B, Mangano S, Faranna P, Pagano A, Locatelli F. Molecular epidemiology of hepatitis C virus infection in dialysis patients. Nephron 1997; 77: 190-6.
15. Nakashima K, Kashiwagi S, Hayashi J, Noguchi A, Hirata M, Kajiyama W, Urabe K, Minami K, Maeda Y. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fuhtoka, Kyushu, Japan. Am J Epidemiol 1992; 136: 1132-7.
16. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, Quinn TC. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - an analysis of 309 sex partnerships. J Infect Dis 1995; 171: 768-75.
17. Hsu HH, Wright TL, Luba D, Martin M, Feinstone SM, Garcia G, Greenberg HB. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology 1991; 14: 763-7.
18. Everhart JE, Di Bisceglie AM, Murray LM, Alter HJ, Melpolder JJ, Kuo G, Hoofnagle JH. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990; 112: 544-5.
19. Vegnente A, Iorio R, Saviano A, Fariello I, Aponte S, Nasca MG, Pensati P. Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis C infection. Pediatr Infect Dis J 1994; 13: 886-9.
20. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn R, Stevens CE, Edwards VM, Werch J. Serum alanine aminotransferase of donors in relation to the risk of non-A non-B hepatitis in recipients. N Engl J Med 1981; 304: 989-94.
21. Kim YS, Pai CH, Chi HS, Kim DW, Min YI, Ahn YO. Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci 1992; 7: 333-6.
22. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-40.